On January 1, 2020, Pfizer Corp. acquired 80% of Vaxx Corp's common stock for P160,000 cash. The fair value of the non-controlling interest at the date was determined to be P40,000. Data from the balance sheets of the two companies included the following accounts as of the date of acquisition: • On the date of the business combination, the book values of Vaxx Corp's net assets and liabilities approximated fair value except for inventory, which has a fair value of P45,000, and land, which had a fair value of P60,000. (using full goodwill
On January 1, 2020, Pfizer Corp. acquired 80% of Vaxx Corp's common stock for P160,000 cash. The fair value of the non-controlling interest at the date was determined to be P40,000. Data from the balance sheets of the two companies included the following accounts as of the date of acquisition: • On the date of the business combination, the book values of Vaxx Corp's net assets and liabilities approximated fair value except for inventory, which has a fair value of P45,000, and land, which had a fair value of P60,000. (using full goodwill
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
Related questions
Question
On January 1, 2020, Pfizer Corp. acquired 80% of Vaxx Corp's common stock for
P160,000 cash. The fair value of the non-controlling interest at the date was determined
to be P40,000. Data from the balance sheets of the two companies included the
following accounts as of the date of acquisition:
• On the date of the business combination, the book values of Vaxx Corp's net assets
and liabilities approximated fair value except for inventory, which has a fair value of
P45,000, and land, which had a fair value of P60,000. (using full goodwill approach).
![Pfizer Corporation Vaxx Corporation
Cash
60,000
20,000
Accounts receivable
80,000
30,000
Inventory
90,000
40,000
Land
100,000
40,000
Buildings and equipment
200,000
150,000
Less: Accumulated depreciation
(80,000)
(50,000)
Investment in Vaxx Corp. stock
160,000
Total Assets
610,000
230,000
Accounts payable
110,000
30,000
Bonds payable
95,000
40,000
Common stock
200,000
40,000
Retained earnings
205,000
120,000
Total Liabilities and Equity
610,000
230,000
What amount of consolidated retained earnings will be reported?](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F6c06a060-4908-4bd0-b74e-9de1aceccb31%2F68c0af0e-8a20-43bb-9278-1ab287df5477%2Fmhsx49k_processed.jpeg&w=3840&q=75)
Transcribed Image Text:Pfizer Corporation Vaxx Corporation
Cash
60,000
20,000
Accounts receivable
80,000
30,000
Inventory
90,000
40,000
Land
100,000
40,000
Buildings and equipment
200,000
150,000
Less: Accumulated depreciation
(80,000)
(50,000)
Investment in Vaxx Corp. stock
160,000
Total Assets
610,000
230,000
Accounts payable
110,000
30,000
Bonds payable
95,000
40,000
Common stock
200,000
40,000
Retained earnings
205,000
120,000
Total Liabilities and Equity
610,000
230,000
What amount of consolidated retained earnings will be reported?
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 2 steps
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Recommended textbooks for you
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![Horngren's Cost Accounting: A Managerial Emphasis…](https://www.bartleby.com/isbn_cover_images/9780134475585/9780134475585_smallCoverImage.gif)
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
![Intermediate Accounting](https://www.bartleby.com/isbn_cover_images/9781259722660/9781259722660_smallCoverImage.gif)
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
![Financial and Managerial Accounting](https://www.bartleby.com/isbn_cover_images/9781259726705/9781259726705_smallCoverImage.gif)
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education